Patients suffering stroke and TBI are found to have a higher level of trimethylamine N-oxide (TMAO) (138, –, 140), which activates various pro-inflammatory responses including NLRP3 inflammasome, MAPK, and NF-κB pathways, predicting higher severity and risk (141, 142). This evidence concerns the gene NFKB1 and stroke disorder.